Complete Filing Data
FinVolution Group reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations of $6.75 billion for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean FinVolution Group did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $2.38B | $2.34B | $2.27B | $2.51B | $1.97B | $2.37B | $2.47B | $1.08B | $501.5M | -$72.1M |
| Revenue * | $13.07B | $12.55B | $11.13B | $4.22B | $3.90B | $1.21B | $197.4M | |||
| Selling And Marketing Expense | $276.0M | $1.89B | $1.69B | $1.58B | $482.9M | $720.3M | $710.8M | $788.3M | $353.0M | $125.4M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $12.6M | $27.8M | $69.0M | -$11.6M | -$75.5M | $12.1M | $43.3M | $99.9M | -$60.5M | -$25.0M |
| Operating Expenses | $10.53B | $10.16B | $8.62B | $6.86B | $5.26B | $3.32B | $2.70B | $2.40B | $978.9M | $340.8M |
| Nonoperating Income Expense | $310.1M | $394.7M | $220.7M | $122.4M | $116.5M | $136.5M | $148.4M | $36.5M | $13.7M | -$365.0K |
| Income Tax Expense Benefit | $457.4M | $395.1M | $454.8M | $240.8M | $455.4M | $482.0M | $151.2M | $274.7M | $48.3M | $4.4M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $389.8M | $2.78B | $2.74B | $2.74B | $2.42B | $2.86B | $2.62B | $1.36B | $549.8M | -$67.8M |
| General And Administrative Expense | $413.5M | $390.0M | $401.7M | $518.2M | $461.1M | $435.8M | $383.4M | $423.8M | $237.8M | $115.9M |
| Comprehensive Income Net Of Tax | $328.2M | $2.37B | $2.34B | $2.50B | $1.90B | $2.38B | $2.51B | $1.18B | $441.0M | -$97.1M |
| Net Income Loss Attributable To Noncontrolling Interest | $4.7M | $42.7M | $14.9M | -$13.6M | -$4.1M | $1.7M | $377.0K | -$76.0K | ||
| Income Taxes Paid | $673.7M | $960.5M | $963.2M | $574.9M | $367.0M | $145.8M | $180.2M | $216.1M | ||
| Revenues Net Of Interest Expense | $12.55B | $11.13B | $9.47B | $7.56B | $5.96B | $4.54B | $3.93B | $1.22B | $195.7M | |
| Interest Income Expense After Provision For Loan Loss | $147.8M | $1.17B | $1.22B | $1.11B | $1.11B | $256.1M | $31.4M | $7.1M | -$1.7M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $2.40B | $2.41B | $2.35B | $2.48B | $1.89B | $2.39B | $2.51B | $1.18B | $441.0M | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $4.7M | $42.7M | $14.9M | -$13.6M | -$4.1M | $1.7M | $377.0K | -$76.0K | ||
| Research And Development Expense | $68.1M | $511.0M | $491.5M | $434.9M | $370.2M | $390.6M | $318.0M | $164.9M | ||
| Deferred Income Tax Assets Net | $344.4M | $1.62B | $919.4M | $455.7M | $155.8M | $129.7M | $122.8M | $128.4M | $31.7M | |
| Deferred Income Tax Liabilities Net | $491.2M | $340.6M | $232.2M | $137.6M | $103.5M | $198.9M | $100.1M | $15.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $15.20B | $13.75B | $12.37B | $10.66B | $8.36B | $7.95B | $5.92B | $3.62B | -$438.4M | -$317.4M | -$111.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $6.75B | $927.4M | $6.48B | $8.49B | $6.12B | $6.01B | $5.29B | $4.28B | $1.21B | $362.3M | |
| Quality Assurance Fund Receivable | $1.64B | $1.76B | $1.67B | $931.8M | $1.12B | $3.65B | $2.06B | $1.15B | $286.8M | $115.5M | $543.0K |
| Provision For Loan And Lease Losses | $82.7M | $415.9M | $374.2M | $463.2M | $299.5M | $192.7M | $46.6M | $34.7M | $5.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$22.3M | $290.3M | -$2.01B | $2.38B | $105.7M | $717.0M | $1.01B | $3.08B | $845.3M | ||
| Loans And Leases Receivable Allowance | $214.6M | $294.4M | $427.9M | $382.0M | $316.1M | $74.4M | $47.7M | $1.1M | $5.9M | ||
| Cash And Cash Equivalents At Carrying Value | $4.67B | $4.97B | $3.64B | $4.42B | $2.63B | $2.32B | $1.62B | $1.89B | $62.2M | $92.5M | $77.3M |
| Retained Earnings Accumulated Deficit | $1.40B | $8.36B | $6.50B | $4.69B | $2.65B | $883.0M | $45.7M | -$2.40B | -$369.1M | ||
| Taxes Payable Current And Noncurrent | $705.9M | $207.5M | $134.0M | $200.6M | $154.4M | $128.3M | $225.1M | $257.1M | $85.2M | ||
| Short Term Investments | $2.83B | $2.96B | $3.43B | $1.20B | $1.97B | $114.6M | $1.69B | $1.96B | $260.0M | ||
| Restricted Cash | $284.2M | $1.80B | $2.84B | $4.07B | $3.48B | $3.69B | $3.68B | $2.39B | $802.9M | ||
| Provision For Doubtful Loan Receivables | $43.8M | $586.8M | $415.9M | $374.2M | $463.2M | $299.5M | $192.7M | $46.6M | |||
| Property Plant And Equipment Net | $85.5M | $140.9M | $141.3M | $112.4M | $93.9M | $134.3M | $144.0M | $108.2M | $37.6M | ||
| Prepaid Expense And Other Assets | $1.29B | $3.38B | $2.97B | $1.90B | $1.05B | $1.39B | $221.8M | $145.7M | $100.4M | ||
| Liabilities And Stockholders Equity | $23.61B | $21.29B | $21.38B | $18.14B | $14.88B | $18.30B | $13.14B | $8.60B | $2.15B | ||
| Liabilities | $8.05B | $7.42B | $8.94B | $7.43B | $6.45B | $10.29B | $7.16B | $4.92B | $1.38B | ||
| Funds Payable To Investors Of Consolidated Trust | $796.1M | $436.4M | $1.85B | $1.80B | $1.66B | $3.66B | $1.51B | $502.6M | $30.1M | ||
| Employee Related Liabilities Current And Noncurrent | $290.4M | $261.5M | $274.4M | $252.9M | $221.0M | $176.7M | $188.3M | $156.8M | $84.5M | ||
| Assets | $23.61B | $21.29B | $21.38B | $18.14B | $14.88B | $18.30B | $13.14B | $8.60B | $2.15B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $12.7M | $80.0M | $52.2M | -$16.8M | -$5.1M | $70.3M | $58.2M | $14.9M | -$85.0M | ||
| Accrued Liabilities And Other Liabilities | $1.23B | $941.8M | $908.7M | $720.0M | $509.0M | $287.6M | $222.5M | $211.6M | $101.3M | ||
| Accounts Receivable Net | $329.6M | $2.21B | $2.22B | $1.89B | $863.9M | $882.3M | $812.0M | $17.8M | $14.2M | ||
| Operating Lease Right Of Use Asset | $5.0M | $38.1M | $192.4M | $49.1M | $55.0M | $95.8M | $127.1M | ||||
| Minority Interest | $47.9M | $122.1M | $72.8M | $54.4M | $67.0M | $63.5M | $61.9M | $60.0M | |||
| Intangible Assets Net Excluding Goodwill | $137.3M | $98.7M | $98.7M | $98.9M | $98.9M | $64.3M | $68.9M | $63.8M | |||
| Goodwill | $6.9M | $50.4M | $50.4M | $50.4M | $50.4M | $50.4M | $50.4M | $50.4M | |||
| Allowance For Doubtful Accounts Receivable | $290.3M | $310.4M | $496.9M | $250.7M | $188.7M | $145.7M | $50.5M | $0.00 | |||
| Additional Paid In Capital Common Stock | $796.7M | $5.75B | $5.69B | $5.69B | $5.66B | $5.64B | $5.90B | $5.95B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$85.3M | -$2.51B | -$763.9M | -$239.8M | -$3.09B | $1.75B | $530.1M | $2.13B | $438.7M | $338.0M |
| Investing Cash Flow * | -$314.5M | $1.41B | -$1.55B | $1.99B | $1.04B | -$828.2M | -$1.45B | -$2.45B | -$684.1M | -$132.2M |
| Operating Cash Flow * | $2.89B | $1.36B | $236.9M | $630.2M | $2.21B | -$215.5M | $1.88B | $3.41B | $1.09B | -$191.9M |
| Proceeds From Loan Originations1 | $938.9M | $7.34B | $10.81B | $7.03B | $12.76B | $10.52B | $2.81B | $369.0M | $1.02B | $118.5M |
| Payments To Acquire Short Term Investments | $7.34B | $11.93B | $17.13B | $12.68B | $8.00B | $3.90B | $12.80B | $8.15B | $292.8M | $34.5M |
| Payments To Acquire Property Plant And Equipment | $27.8M | $538.1M | $52.8M | $55.3M | $11.0M | $48.7M | $83.6M | $90.9M | $29.8M | $17.5M |
| Payments To Acquire Loans Held For Investment | $9.35B | $5.83B | $10.08B | $5.81B | $9.83B | $12.13B | $4.33B | $1.02B | $1.45B | $177.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$233.7M | -$125.0M | $1.15B | $875.3M | -$353.4M | $1.09B | $115.0M | $70.7M | $3.7M | $43.7M |
| Increase Decrease In Employee Related Liabilities | $3.9M | -$12.9M | $21.5M | $31.9M | $44.3M | -$11.6M | $31.4M | $72.3M | $49.9M | $29.7M |
| Increase Decrease In Deferred Income Taxes | $863.3M | $705.0M | $463.6M | $300.0M | -$151.3M | $7.0M | $27.7M | $112.6M | $16.8M | $14.9M |
| Increase Decrease In Accrued Taxes Payable | $68.4M | $73.5M | -$66.6M | $46.3M | $26.1M | -$96.8M | -$32.0M | $171.9M | $54.5M | $27.4M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $157.6M | -$9.8M | $155.5M | $107.5M | -$359.8M | $93.5M | $16.7M | $108.4M | $34.3M | $2.3M |
| Proceeds From Sale Of Short Term Investments | $7.52B | $12.43B | $15.01B | $13.53B | $6.18B | $5.53B | $13.12B | $6.49B | $68.5M | |
| Payments To Acquire Equity Method Investments | $35.2M | $67.8M | $119.9M | $31.2M | $36.8M | $803.7M | $155.3M | $10.0M | $2.4M | |
| Share Based Compensation | $144.1M | $116.4M | $89.0M | $95.2M | $42.2M | $42.3M | $50.3M | $106.2M | ||
| Increase Decrease In Guarantee And Quality Assurance Fund Receivable | $36.0M | $440.1M | $914.4M | -$130.6M | -$2.54B | $1.80B | $911.6M | $866.0M | $171.3M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $419.0K | $22.4M | $67.8M | -$10.1M | -$51.5M | $11.3M | $42.0M | -$15.4M | $2.5M | |
| Increase Decrease In Due To Related Parties | -$866.0K | -$1.3M | $281.0K | -$2.3M | $4.3M | -$12.0M | -$3.5M | $15.6M | ||
| Increase Decrease In Deferred Tax Liabilities | $141.7M | $108.4M | $94.6M | $34.1M | $14.8M | $98.9M | $84.1M | $15.9M | ||
| Increase Decrease In Contract With Customer Liability | $5.1M | $0.00 | -$3.3M | $5.0M | -$52.3M | -$109.7M | -$97.1M | $102.2M | $149.2M | |
| Payments For Repurchase Of Common Stock | $643.2M | $694.5M | $340.8M | $26.0M | $380.0M | $42.3M | $452.3M | |||
| Proceeds From Stock Options Exercised | $2.3M | $10.6M | $33.3M | $6.6M | $31.6M | $14.0M | ||||
| Increase Decrease In Due From Related Parties | $968.0K | $0.00 | $0.00 | $0.00 | -$2.8M | $2.8M | $123.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $1.81 | $1.67 | $1.56 | $1.69 | $1.32 | $1.53 | $1.54 | -$2.55 | -$0.09 | -$0.27 |
| Earnings Per Share Basic | $1.85 | $1.70 | $1.60 | $1.77 | $1.34 | $1.56 | $1.65 | $-2.55 | $-0.09 | |
| Weighted Average Number Of Shares Outstanding Basic | 1.29B | 1.37B | 1.41B | 1.42B | 1.48B | 1.53B | 1.50B | 779.8M | 665.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation And Amortization | $69.5M | $22.5M | $23.8M | $37.3M | $51.8M | $57.7M | $42.2M | $22.6M | $12.1M | $3.3M |
| Interest Paid Net | $5.2M | $87.1M | $83.4M | $161.4M | $268.2M | $95.0M | $58.3M | $5.4M | $554.0K | |
| Gain Loss On Sales Of Loans Net | $853.8M | $1.05B | $1.17B | $1.22B | $1.11B | $1.11B | $256.1M | $31.4M | $41.8M | |
| Change In Fair Value Of Short Term Investment | $6.2M | $32.5M | $9.8M | $1.6M | $7.2M | -$13.0M | $16.5M | $3.9M | ||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $1.1M | $1.1M | $607.0K | $292.0K | $917.0K | $6.6M | |||
| Statutory Accounting Practices Statutory Capital And Surplus Balance | $852.7M | $762.5M | $698.4M | $610.4M | $458.1M | $317.2M | $256.0M | $55.1M | $15.7M |
Most recent annual filing with the SEC: April 18, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.